1. Human Immunodeficiency Virus Seroprevalence among Inmates of the Penitentiary Complex of the Region of Campinas, State of São Paulo, Brazil
- Author
-
Antonio Fernando Pestana de Castro, L. C. Ricci, and Neusa Maria Osti
- Subjects
Adult ,Male ,Microbiology (medical) ,lcsh:Arctic medicine. Tropical medicine ,inmates ,lcsh:RC955-962 ,RC955-962 ,Human immunodeficiency virus (HIV) ,lcsh:QR1-502 ,HIV Infections ,human immunodeficiency virus seroprevalence ,medicine.disease_cause ,Microbiology ,lcsh:Microbiology ,Serology ,HIV Seroprevalence ,Arctic medicine. Tropical medicine ,Prevalence ,Humans ,Seroprevalence ,Medicine ,Aged ,business.industry ,Prisoners ,virus diseases ,Middle Aged ,Virology ,QR1-502 ,Campinas ,business ,Brazil - Abstract
Six hundred and ninety three male inmates from three penitentiaries, two (A and B) maximum-security systems and one (C) minimum-security facility, located in Campinas, State of São Paulo, Brazil were studied for the presence of human immunodeficiency virus (HIV) antibodies, using a cross-sectional design. The search for anti-HIV antibodies in 693 samples of sera collected was carried out by two serological tests: (a) the Microparticle enzyme immunoassay-HIV-1 and HIV-2 (MEIA) (Abbott Laboratories) and (b) the Western Blot-HIV-1 (WB) (Cambridge Biotech Corporation) to confirm positive results with MEIA. Sera reactivity for HIV antibodies was 14.4%. The highest frequency of anti-HIV antibodies was found in the A and B maximum-security prisons: 17% and 21.5%, respectively. In prison C, the frequency of reagents was 10.9%. Seventy three inmates, initially negative in the MEIA test, were checked again five and seven months later. Three of them, all from the maximum-security facilities, became reactive in the MEIA test, with confirmation in the WB, suggesting that serological conversion had occurred after imprisonment.
- Published
- 1999